社区医疗系统肺癌筛查结果与NLST的比较
该研究在一个社区健康系统内分析了6161次肺癌筛查(LCS),涵盖10个站点、7家医院和3个独立影像中心。结论认为社区环境下LCS的诊断、分期迁移、干预频率和不良事件率与NLST相似,可安全成功开展。
要点
- 社区肺癌筛查的肺癌诊断和分期分布与NLST相似。
- 筛查后干预率14.6%,侵入性操作率6.6%,不良事件率10.1%。
- 手术死亡率2.3%,气胸最常见(10例,6例需引流)。
核心结论
- 社区健康系统开展的肺癌筛查在肺癌诊断、分期迁移、干预频率和不良事件率方面与NLST相似。
- 该研究证实肺癌筛查可在社区医疗环境中成功、安全地实施,且效果与NLST相当。
研究设计与样本
- 前瞻性收集2013年11月至2018年12月数据并回顾性分析。
- 筛查项目包括10个站点:7家医院(2家非大学三级 care,5家社区)和3个独立影像中心。
- 由基层临床医生转诊,采用标准标准确定资格,专职放射科医生解读所有筛查并分配Lung-RADS分类。
- 所有Lung-RADS 4类扫描均经多学科审查和管理建议。
- 共4666例转诊,排除或拒绝1264人,3402人接受初始筛查;第2至第8次筛查在2758名患者中进行,总计6161次筛查。
主要发现
- 筛查后干预率为14.6%(500人),最常见为额外影像检查。
- 侵入性干预226例,包括141例诊断性操作和85例手术,涉及176人(操作率6.6%)。
- 操作不良事件率23/226(10.1%),涉及21名患者(占所有筛查者的0.6%)。
- 气胸最常见(10例),其中6例需胸腔引流;85例手术中2例死亡,手术死亡率2.3%。
关键数值与推荐
- Lung-RADS 4类扫描均接受多学科审查。
- 干预率14.6%,侵入性操作率6.6%,不良事件率10.1%,手术死亡率2.3%。
临床怎么用
- 社区医疗系统可参考本研究模式建立肺癌筛查项目,由基层医生转诊、放射科医生使用Lung-RADS分类解读。
- 对Lung-RADS 4类扫描应实施多学科审查以制定管理建议。
- 筛查中需关注气胸等不良事件,并具备胸腔引流等处理能力。
局限性
- 本研究为单社区健康系统的回顾性分析,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To address doubts regarding National Lung Screening Trial (NLST) generalizability, we analyzed over 6,000 lung cancer screenings (LCSs) within a community health system. METHODS: Our LCS program included 10 sites, 7 hospitals (2 non-university tertiary care, 5 community) and 3 free-standing imaging centers. Primary care clinicians referred patients. Standard criteria determined eligibility. Dedicated radiologists interpreted all LCSs, assigning Lung Imaging Reporting and Data System (Lung-RADS) categories. All category 4 Lung-RADS scans underwent multidisciplinary review and management recommendations. Data was prospectively collected from November 2013 through December 2018 and retrospectively analyzed. RESULTS: Of 4,666 referrals, 1,264 individuals were excluded or declined, and 3,402 individuals underwent initial LCS. Second through eighth LCSs were performed on 2,758 patients, for a total of 6,161 LCSs. Intervention rate after LCS was 14.6% (500 individuals) and was most often additional imaging. Invasive interventions (n = 226) were performed, including 141 diagnostic procedures and 85 surgeries in 176 individuals (procedure rate 6.6%). Ninety-five lung cancers were diagnosed: 84 non-small cell (stage 1: 60; stage 2: 7; stage 3: 9; stage 4: 8), and 11 small cell lung cancers. The procedural adverse event rate was 23/226 (10.1%) in 21 patients (0.6% of all screened individuals). Pneumothorax (n = 10) was the most frequent, 6 requiring pleural drainage. There were 2 deaths among 85 surgeries or 2.3% surgical mortality. CONCLUSIONS: Our LCS experience in a community setting demonstrated lung cancer diagnosis, stage shift, intervention frequency, and adverse event rate similar to the NLST. This study confirms that LCS can be performed successfully, safely, and with equivalence to the NLST in a community health care setting.
引用
- Handy JR, Skokan M, Rauch E, et al. Results of Lung Cancer Screening in the Community. Ann Fam Med. 2020. PMID: 32393560. doi:10.1370/afm.2519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。